0001144204-19-044292.txt : 20190911 0001144204-19-044292.hdr.sgml : 20190911 20190911184826 ACCESSION NUMBER: 0001144204-19-044292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190909 FILED AS OF DATE: 20190911 DATE AS OF CHANGE: 20190911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goel Shubh CENTRAL INDEX KEY: 0001787942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32295 FILM NUMBER: 191089245 MAIL ADDRESS: STREET 1: 1100 MAXWELL, #522 CITY: HOBOKEN STATE: NJ ZIP: 07030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001211583 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (919) 636-4530 MAIL ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20140903 FORMER COMPANY: FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC DATE OF NAME CHANGE: 20021223 4 1 tv529267_4.xml OWNERSHIP DOCUMENT X0306 4 2019-09-09 0 0001211583 FENNEC PHARMACEUTICALS INC. FENC 0001787942 Goel Shubh 68 TW ALEXANDER DRIVE, PO BOX 13628 DURHAM NC 27709 0 1 0 0 Chief Commercial Officer Stock Option (right to buy) 4.74 2019-09-09 4 A 0 175000 0 A 2029-09-09 Common Shares 175000 175000 D On September 9, 2019, Shubh Goel was granted an incentive stock option to purchase 175,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan. 1/3 of the shares subject to this option shall vest and may be exercised as of September 9, 2020 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of September 9, 2022 and thereafter, 100% of the total number of shares subject to this option shall be vested. /s/ Goel Shubh, Chief Commercial Officer 2019-09-11